Gastroretentive Platform (Oncology focus)

About Enzian Pharmaceutics

Enzian Pharmaceutics, founded in 2016 and based in Zug, Switzerland, is innovating in the drug delivery sector with a proprietary platform for gastroretentive oral dosage forms. The company's technology utilizes a unique 3D-printed fibrous microstructure that expands in the stomach to enable prolonged, constant drug release, addressing a key limitation of conventional tablets and capsules. This approach seeks to maintain optimal drug concentrations in the blood, potentially improving treatment outcomes for drugs with solubility challenges. Enzian is developing its manufacturing process and advancing its lead programs toward clinical validation.

Therapeutic Areas